$226.56
0.22%
Downside
Day's Volatility :1.1%
Upside
0.88%
15.83%
Downside
52 Weeks Volatility :17.35%
Upside
1.81%
Period | Cme Group Inc. | Sector (Financials) | S&P500 |
---|---|---|---|
3 Months | 8.88% | 13.1% | 5.3% |
6 Months | 8.39% | 17.4% | 11.2% |
1 Year | 5.77% | 41.0% | 30.4% |
3 Years | 1.64% | 27.0% | 26.0% |
Market Capitalization | 82.2B |
Book Value | $78.47 |
Dividend Share | 4.55 |
Dividend Yield | 2.0% |
Earnings Per Share (EPS) | 9.51 |
PE Ratio | 23.97 |
PEG Ratio | 7.98 |
Wall Street Target Price | 235.25 |
Profit Margin | 57.43% |
Operating Margin TTM | 64.75% |
Return On Assets TTM | 1.84% |
Return On Equity TTM | 12.3% |
Revenue TTM | 6.0B |
Revenue Per Share TTM | 16.8 |
Quarterly Revenue Growth YOY | 18.5% |
Gross Profit TTM | 5.0B |
EBITDA | 4.2B |
Diluted Eps TTM | 9.51 |
Quarterly Earnings Growth YOY | 0.21 |
EPS Estimate Current Year | 10.21 |
EPS Estimate Next Year | 10.37 |
EPS Estimate Current Quarter | 2.65 |
EPS Estimate Next Quarter | 2.47 |
What analysts predicted
Upside of 3.84%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 4.3B | ↑ 18.24% |
Net Income | 2.0B | ↓ 51.71% |
Net Profit Margin | 45.53% | ↓ 65.96% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 4.9B | ↑ 12.96% |
Net Income | 2.1B | ↑ 7.86% |
Net Profit Margin | 43.48% | ↓ 2.05% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 4.9B | ↑ 0.32% |
Net Income | 2.1B | ↓ 0.53% |
Net Profit Margin | 43.11% | ↓ 0.37% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 4.7B | ↓ 3.97% |
Net Income | 2.6B | ↑ 25.23% |
Net Profit Margin | 56.22% | ↑ 13.11% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 5.0B | ↑ 7.03% |
Net Income | 2.7B | ↑ 2.07% |
Net Profit Margin | 53.61% | ↓ 2.61% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 5.6B | ↑ 11.15% |
Net Income | 3.2B | ↑ 19.89% |
Net Profit Margin | 57.83% | ↑ 4.22% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4B | ↓ 5.65% |
Net Income | 777.6M | ↓ 12.02% |
Net Profit Margin | 57.17% | ↓ 4.14% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.3B | ↓ 1.65% |
Net Income | 750.2M | ↓ 3.52% |
Net Profit Margin | 56.08% | ↓ 1.09% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4B | ↑ 7.59% |
Net Income | 814.6M | ↑ 8.58% |
Net Profit Margin | 56.6% | ↑ 0.52% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↑ 3.38% |
Net Income | 855.2M | ↑ 4.98% |
Net Profit Margin | 57.48% | ↑ 0.88% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↑ 3.0% |
Net Income | 883.2M | ↑ 3.27% |
Net Profit Margin | 57.63% | ↑ 0.15% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↑ 3.39% |
Net Income | 879.4M | ↓ 0.43% |
Net Profit Margin | 55.5% | ↓ 2.13% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 77.5B | ↑ 2.22% |
Total Liabilities | 51.5B | ↓ 3.5% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 75.2B | ↓ 2.92% |
Total Liabilities | 49.1B | ↓ 4.76% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 124.7B | ↑ 65.74% |
Total Liabilities | 98.3B | ↑ 100.4% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 196.8B | ↑ 57.85% |
Total Liabilities | 169.4B | ↑ 72.3% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 174.2B | ↓ 11.49% |
Total Liabilities | 147.3B | ↓ 13.04% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 129.7B | ↓ 25.53% |
Total Liabilities | 103.0B | ↓ 30.09% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 151.3B | ↓ 8.88% |
Total Liabilities | 123.5B | ↓ 10.95% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 125.6B | ↓ 16.99% |
Total Liabilities | 97.4B | ↓ 21.08% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 129.8B | ↑ 3.38% |
Total Liabilities | 103.1B | ↑ 5.8% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 132.1B | ↑ 1.7% |
Total Liabilities | 104.9B | ↑ 1.74% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 123.4B | ↓ 6.57% |
Total Liabilities | 95.7B | ↓ 8.73% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 137.8B | ↑ 11.68% |
Total Liabilities | 109.6B | ↑ 14.45% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.4B | ↑ 32.62% |
Investing Cash Flow | -1.9B | ↓ 1150.36% |
Financing Cash Flow | -1.1B | ↓ 45.6% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.7B | ↑ 9.51% |
Investing Cash Flow | -152.6M | ↓ 91.92% |
Financing Cash Flow | -2.3B | ↑ 116.74% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.7B | ↑ 1.6% |
Investing Cash Flow | -175.5M | ↑ 15.01% |
Financing Cash Flow | -2.5B | ↑ 5.02% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.4B | ↓ 11.53% |
Investing Cash Flow | 58.4M | ↓ 133.28% |
Financing Cash Flow | 69.9B | ↓ 2943.9% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.1B | ↑ 27.21% |
Investing Cash Flow | -489.8M | ↓ 938.7% |
Financing Cash Flow | -25.4B | ↓ 136.31% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 650.4M | ↓ 27.93% |
Investing Cash Flow | 78.0M | ↓ 553.49% |
Financing Cash Flow | -15.3B | ↑ 65.92% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 856.7M | ↑ 31.72% |
Investing Cash Flow | -19.5M | ↓ 125.0% |
Financing Cash Flow | -26.5B | ↑ 73.41% |
Sell
Neutral
Buy
Cme Group Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Cme Group Inc. | 0.42% | 8.39% | 5.77% | 1.64% | 10.95% |
Moody's Corporation | -2.54% | 14.93% | 30.45% | 23.41% | 111.74% |
Coinbase Global Inc | 49.73% | 41.74% | 203.36% | 1.44% | -2.52% |
Intercontinental Exchange, Inc. | -6.35% | 13.48% | 37.3% | 17.14% | 65.91% |
S&p Global, Inc. | -3.83% | 14.38% | 21.6% | 9.82% | 90.3% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Cme Group Inc. | 24.15 | 23.97 | 7.98 | 10.21 | 0.12 | 0.02 | 0.02 | 78.47 |
Moody's Corporation | 43.3 | 43.3 | 2.47 | 12.11 | 0.54 | 0.12 | 0.01 | 21.55 |
Coinbase Global Inc | 55.15 | 55.29 | 1.09 | 5.32 | 0.21 | 0.0 | NA | 34.87 |
Intercontinental Exchange, Inc. | 36.86 | 37.42 | 2.5 | 6.08 | 0.09 | 0.02 | 0.01 | 47.44 |
S&p Global, Inc. | 44.43 | 44.26 | 1.5 | 15.27 | 0.1 | 0.06 | 0.01 | 109.55 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Cme Group Inc. | Buy | $82.8B | 10.95% | 24.15 | 57.43% |
Moody's Corporation | Buy | $85.8B | 111.74% | 43.3 | 29.05% |
Coinbase Global Inc | Buy | $76.6B | -2.52% | 55.15 | 31.22% |
Intercontinental Exchange, Inc. | Buy | $89.3B | 65.91% | 36.86 | 26.53% |
S&p Global, Inc. | Buy | $156.1B | 90.3% | 44.43 | 25.79% |
Insights on Cme Group Inc.
Revenue is up for the last 5 quarters, 1.33B → 1.58B (in $), with an average increase of 4.1% per quarter
Netprofit is down for the last 2 quarters, 883.2M → 879.4M (in $), with an average decrease of 0.4% per quarter
In the last 1 year, Coinbase Global Inc has given 203.4% return, outperforming this stock by 197.6%
Vanguard Group Inc
BlackRock Inc
State Street Corp
Morgan Stanley - Brokerage Accounts
Capital World Investors
JPMorgan Chase & Co
In the quarter ending March,2024. Cme Group Inc. has declared dividend of $1.15
Read Moreas the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
Organization | Cme Group Inc. |
Employees | 3565 |
CEO | Mr. Terrence A. Duffy |
Industry | Finance |
Pnc Financial Services Group, Inc.
$226.56
-0.63%
Fair Isaac Corp
$226.56
-0.63%
Ge Healthcare Technologies Inc.
$226.56
-0.63%
Small Cap Value Etf Vanguard
$226.56
-0.63%
Xylem Inc.
$226.56
-0.63%
Cubesmart
$226.56
-0.63%
Banco De Chile
$226.56
-0.63%
Jpmorgan Usd Emerg Markets Bond Ishares
$226.56
-0.63%
Markel Group Inc
$226.56
-0.63%